PlainRecalls
FDA Drug Low Class III Terminated

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

Reported: October 2, 2019 Initiated: September 12, 2019 #D-0002-2020

Product Description

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.

Details

Recalling Firm
Pfizer Inc.
Units Affected
7,686 100-count bottles
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24. Recalled by Pfizer Inc.. Units affected: 7,686 100-count bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 2, 2019. Severity: Low. Recall number: D-0002-2020.